Literature DB >> 9194943

Particulate air pollution: possible relevance in asthma.

M M Glovsky1, A G Miguel, G R Cass.   

Abstract

The relative importance of air pollution in the pathogenesis of bronchial asthma has been of interest for several decades. Numerous studies on the role of gaseous air pollution containing ozone, nitrogen dioxide, sulfur dioxide, and carbon monoxide have been published. Very little attention has been focused on the role of respirable particles in the causation of asthma. In this article we summarize some of our ongoing investigations into the sources and composition of airborne particles in the Los Angeles and Pasadena atmosphere, including the search for biologically active particles that may induce asthma attacks. If is found that the urban atmosphere contains not only combustion-derived particles from diesel engine exhaust and gasoline-powered motor vehicle exhaust, but also particles formed from biological starting materials including plant debris, cigarette smoke, wood smoke, and meat smoke as well as tire debris containing some natural rubber and paved road dust. Paved road dust is a very complex mixture of particles including garden soil, tire dust, plant fragments, redeposited atmospheric particles of all types, and pollen fragments presumably ground up by passing traffic. We have shown previously that latex allergen can be extracted from tire dust, from roadside dust, and from respirable air samples taken at Los Angeles and Long Beach. At present, work is underway to identify the larger range of allergens that may be contributed by the entrainment of paved road dust into the atmosphere. The possible importance of pollen fragments present in paved road dust in very small particle sizes is discussed as well as their potential relevance in asthma.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9194943     DOI: 10.2500/108854197778984392

Source DB:  PubMed          Journal:  Allergy Asthma Proc        ISSN: 1088-5412            Impact factor:   2.587


  8 in total

Review 1.  Prevalence and mechanisms of development of asthma and airway hyperresponsiveness in athletes.

Authors:  J B Langdeau; L P Boulet
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

2.  Comparative Toxicity of Fly Ash: An In Vitro Study.

Authors:  Elvira Rozhina; Ilnur Ishmukhametov; Läysän Nigamatzyanova; Farida Akhatova; Svetlana Batasheva; Sergey Taskaev; Carlos Montes; Yuri Lvov; Rawil Fakhrullin
Journal:  Molecules       Date:  2021-03-30       Impact factor: 4.411

Review 3.  Best practices for pediatric asthma: improved clinical management for the inner-city patient.

Authors:  C A Jones
Journal:  J Natl Med Assoc       Date:  1999-08       Impact factor: 1.798

4.  Combustion-generated nanoparticulates in the El Paso, TX, USA / Juarez, Mexico Metroplex: their comparative characterization and potential for adverse health effects.

Authors:  L E Murr; K F Soto; K M Garza; P A Guerrero; F Martinez; E V Esquivel; D A Ramirez; Y Shi; J J Bang; J Venzor
Journal:  Int J Environ Res Public Health       Date:  2006-03       Impact factor: 3.390

Review 5.  Current prevalence rate of latex allergy: Why it remains a problem?

Authors:  Miaozong Wu; James McIntosh; Jian Liu
Journal:  J Occup Health       Date:  2016-03-24       Impact factor: 2.708

Review 6.  Inhaled environmental allergens and toxicants as determinants of the asthma phenotype.

Authors:  Kristin Sokol; Sanjiv Sur; Bill T Ameredes
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

Review 7.  Epidemiologic evidence for asthma and exposure to air toxics: linkages between occupational, indoor, and community air pollution research.

Authors:  Ralph J Delfino
Journal:  Environ Health Perspect       Date:  2002-08       Impact factor: 9.031

Review 8.  Exposure assessment for atmospheric ultrafine particles (UFPs) and implications in epidemiologic research.

Authors:  Constantinos Sioutas; Ralph J Delfino; Manisha Singh
Journal:  Environ Health Perspect       Date:  2005-08       Impact factor: 9.031

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.